Zydus Wellness Limited CC-Nov25.pdf · 2025-11-05
So I have 2 questions. One is trying to understand what Q3 and Q4 will look like. My understanding is that we've had a difficult Q2 because of the challenges in the seasonal category, which is I understand Nycil and Glucon-D. I also remember from last quarter's call that 80% to 90% of sales for Glucon-D and Nycil are booked in Q1 and Q2. So while you're still targeting that 17%-ish margin for the full year, do you have any thoughts on where will that specifically come from? Or how do we achieve that? Because I'm assuming these 2 products will continue to underperform for Q3 and Q4?
Understood. And good to know that Q4 still presents potential on those categories. My second question is really about how you're looking at the business over a 3- to 5-year horizon. Are you seeing all of the different product categories contributing more or less evenly to the growth? Or are you seeing 1 or 2 categories as being the blockbusters that will really drive the future of the company?